Prospective, Randomized, Open-Label, Blinded Endpoints, Multi-Center Study to Evaluate the Efficacy of Modest Blood Pressure Reduction With Diovan (Valsartan) in Acute Ischemic Stroke.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms VENTURE
- 06 Feb 2013 Primary endpoint 'Rankin-scale' has not been met.
- 06 Feb 2013 Primary endpoint 'Death-rate' has not been met.
- 06 Feb 2013 Results presented at the 38th International Stroke Conference.